Cited by 109Alzheimer's disease research and treatmentsExtracellular vesicles in diseaseCellular transport and secretion

Apolipoprotein E4 genotype compromises brain exosome production

Open access
Peng, Katherine Y, Pérez-González, Rocío, Alldred, Melissa J, Goulbourne, Chris N, Morales-Corraliza, Jose, Saito, Mariko, Saito, Mitsuo, Ginsberg, Stephen D +2 more·2019·Brain

Abstract

In addition to being the greatest genetic risk factor for Alzheimer's disease, expression of the ɛ4 allele of apolipoprotein E can lead to cognitive decline during ageing that is independent of Alzheimer's amyloid-β and tau pathology. In human post-mortem tissue and mouse models humanized for apolipoprotein E, we examined the impact of apolipoprotein E4 expression on brain exosomes, vesicles that are produced within and secreted from late-endocytic multivesicular bodies. Compared to humans or mice homozygous for the risk-neutral ɛ3 allele we show that the ɛ4 allele, whether homozygous or heterozygous with an ɛ3 allele, drives lower exosome levels in the brain extracellular space. In mice, we show that the apolipoprotein E4-driven change in brain exosome levels is age-dependent: while not present at age 6 months, it is detectable at 12 months of age. Expression levels of the exosome pathway regulators tumor susceptibility gene 101 (TSG101) and Ras-related protein Rab35 (RAB35) were found to be reduced in the brain at the protein and mRNA levels, arguing that apolipoprotein E4 genotype leads to a downregulation of exosome biosynthesis and release. Compromised exosome production is likely to have adverse effects, including diminishing a cell's ability to eliminate materials from the endosomal-lysosomal system. This reduction in brain exosome levels in 12-month-old apolipoprotein E4 mice occurs earlier than our previously reported brain endosomal pathway changes, arguing that an apolipoprotein E4-driven failure in exosome production plays a primary role in endosomal and lysosomal deficits that occur in apolipoprotein E4 mouse and human brains. Disruption of these interdependent endosomal-exosomal-lysosomal systems in apolipoprotein E4-expressing individuals may contribute to amyloidogenic amyloid-β precursor protein processing, compromise trophic signalling and synaptic function, and interfere with a neuron's ability to degrade material, all of which are events that lead to neuronal vulnerability and higher risk of Alzheimer's disease development. Together, these data suggest that exosome pathway dysfunction is a previously unappreciated component of the brain pathologies that occur as a result of apolipoprotein E4 expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awy289

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APOE isoforms influence EV biogenesis and cargo through effects on lipid membrane dynamics and endosomal trafficking.

    “APOE isoforms influence EV biogenesis and cargo through effects on lipid membrane dynamics and endosomal trafficking. 28 , 29”

    From Plasma extracellular vesicles from <i>APOE3</i> Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer's disease (2026) · cites this paper as [29]

    The Results (page not provided) report altered extracellular-vesicle lipid composition in APOE4 versus APOE3 mice, and the paper reports lower brain exosome levels with APOE4. The Discussion (page not provided) proposes that altered cholesterol metabolism and endosomal pathways may link APOE4 to reduced exosome production, but it presents that mechanism as a suggestion rather than an established causal pathway. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Peng, K. Y., Pérez-González, R., Alldred, M. J., Goulbourne, C. N., Morales-Corraliza, J., Saito, M., Saito, M., Ginsberg, S. D., Mathews, P. M., & Levy, E.
Affiliations
  • Nathan Kline Institute for Psychiatric Research (US)
  • Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, New York, USA
Corresponding author
  • Mathews, Paul M
  • Levy, Efrat
Venue
Brain
Published
2018-11-27
Volume
142
Issue
1
Pages
163-175
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2905324087
Cited by
109
References
58
Citations by year
2026: 11 · 2025: 9 · 2024: 8 · 2023: 8 · 2022: 22 · 2021: 22 · 2020: 17 · 2019: 11 · 2018: 1
FWCI
8.48
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • NIH (P01 AG017617, R01 AG057517, R01 AG043375, P01 AG014449, T32-GM066704, T32-AG052909, AG025688)
  • Drs Thomas Wisniewski and Helen Scharfman
  • Sackler Institute of Graduate Biomedical Sciences
  • New York University School of Medicine
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
APOE ε4, Alzheimer's disease, TSG101, Rab35, multivesicular bodies, endosomal-lysosomal system, cognitive decline, synaptic function, neuronal vulnerability
MeSH terms
Tsg101 Protein, Aged, Aged, 80 and over, Aging, Alleles, Animals, Brain, DNA-Binding Proteins, Extracellular Space, Female, Genotype, Humans, Male, Mice, Transgenic, Middle Aged, Transcription Factors, Down-Regulation, rab GTP-Binding Proteins, Lipid Metabolism, Mice, Apolipoprotein E3, Apolipoprotein E4, Exosomes, Endosomal Sorting Complexes Required for Transport

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review